TY - JOUR
T1 - Artificial multi-enzyme cascades and whole-cell transformation for bioconversion of C1 compounds
T2 - Advances, challenge and perspectives
AU - Qiao, Yangyi
AU - Ma, Wenyue
AU - Zhang, Shangjie
AU - Guo, Feng
AU - Liu, Kang
AU - Jiang, Yujia
AU - Wang, Yanxia
AU - Xin, Fengxue
AU - Zhang, Wenming
AU - Jiang, Min
N1 - Publisher Copyright:
© 2023 The Authors
PY - 2023/12
Y1 - 2023/12
N2 - Artificial multi-enzyme cascades bear great potential for bioconversion of C1 compounds to value-added chemicals. Over the past decade, massive efforts have been devoted to constructing multi-enzyme cascades to produce glycolic acid, rare functional sugars and even starch from C1 compounds. However, in contrast to traditional fermentation utilizing C1 compounds with the expectation of competitive economic performance in future industrialization, multi-enzyme cascades systems in the proof-of-concept phase are facing the challenges of upscaling. Here, we offered an overview of the recent advances in the construction of in vitro multi-enzyme cascades and whole-cell transformation using C1 compounds as substrate. In addition, the existing challenges and possible solutions were also discussed aiming to combine the strengths of in vitro and in vivo multi-enzyme cascades systems for upscaling.
AB - Artificial multi-enzyme cascades bear great potential for bioconversion of C1 compounds to value-added chemicals. Over the past decade, massive efforts have been devoted to constructing multi-enzyme cascades to produce glycolic acid, rare functional sugars and even starch from C1 compounds. However, in contrast to traditional fermentation utilizing C1 compounds with the expectation of competitive economic performance in future industrialization, multi-enzyme cascades systems in the proof-of-concept phase are facing the challenges of upscaling. Here, we offered an overview of the recent advances in the construction of in vitro multi-enzyme cascades and whole-cell transformation using C1 compounds as substrate. In addition, the existing challenges and possible solutions were also discussed aiming to combine the strengths of in vitro and in vivo multi-enzyme cascades systems for upscaling.
UR - http://www.scopus.com/inward/record.url?scp=85169887634&partnerID=8YFLogxK
U2 - 10.1016/j.synbio.2023.08.008
DO - 10.1016/j.synbio.2023.08.008
M3 - 文献综述
AN - SCOPUS:85169887634
SN - 2405-805X
VL - 8
SP - 578
EP - 583
JO - Synthetic and Systems Biotechnology
JF - Synthetic and Systems Biotechnology
IS - 4
ER -